Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -6.08 | -0.00 | 0.21 | 2.66 |
| FCF Yield | -0.85% | -36.90% | -33.31% | -8.68% |
| EV / EBITDA | 24.72 | -1.03 | -11.77 | -12.91 |
| Quality | ||||
| ROIC | 2.92% | -27.49% | -11.46% | -13.42% |
| Gross Margin | 75.35% | 73.50% | -7.78% | -13.95% |
| Cash Conversion Ratio | -0.46 | 0.26 | 2.94 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.50% | 14.74% | 8.56% | -0.88% |
| Free Cash Flow Growth | 96.52% | 42.26% | -51.61% | -3.70% |
| Safety | ||||
| Net Debt / EBITDA | -9.47 | 0.25 | 5.16 | 1.37 |
| Interest Coverage | 0.00 | -128.36 | -151.86 | -152.38 |
| Efficiency | ||||
| Inventory Turnover | 1.02 | 1.00 | 4.16 | 3.52 |
| Cash Conversion Cycle | 182.28 | 99.34 | 49.02 | 70.86 |